CK19 is superior to MUC1 as a marker of micrometastases in patients with non-small cell lung cancer (NSCLC)

Journal of the American College of Surgeons(2000)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要